| Date Filed | Type | Description |
| 05/19/2023 |
4
| CHAI CHRISTOPHER Y (Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 20,000 options to buy
@ $0.56, valued at
$11.2k
|
|
| 06/09/2022 |
4
| CHAI CHRISTOPHER Y (Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 20,000 options to buy
@ $2.79, valued at
$55.8k
|
|
| 08/16/2021 |
3
| CHAI CHRISTOPHER Y (Director) has filed a Form 3 on Surrozen, Inc./DE |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 7,500 shares
@ $99.3653, valued at
$745.2k
Exercised 7,500 options to buy
@ $2.9977, valued at
$22.5k
|
|
| 05/21/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 7,500 shares
@ $65.1024, valued at
$488.3k
Exercised 5,675 options to buy
@ $2.9977, valued at
$17k
|
|
| 03/05/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 02/20/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 2,684 shares
@ $63.8558, valued at
$171.4k
Sold 545 shares
@ $64.9075, valued at
$35.4k
Sold 1,350 shares
@ $65.9415, valued at
$89k
Sold 605 shares
@ $67.078, valued at
$40.6k
Sold 2,240 shares
@ $68.1302, valued at
$152.6k
Sold 76 shares
@ $68.5218, valued at
$5.2k
Exercised 2,500 options to buy
@ $2.9977, valued at
$7.5k
|
|
| 03/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2018 |
3
| CHAI CHRISTOPHER Y (CFO) has filed a Form 3 on Principia Biopharma Inc. |
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2013 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 01/27/2012 |
4
| CHAI CHRISTOPHER Y (SVP & CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 943 shares
@ $13.84, valued at
$13.1k
Granted 32,500 options to buy
@ $14.09, valued at
$457.9k
Granted 11,000 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 01/27/2012 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 09/22/2011 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Sold 32,000 shares
@ $15.3837, valued at
$492.3k
Exercised 32,000 options to buy
@ $0.7434, valued at
$23.8k
|
|
| 02/03/2011 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 01/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/25/2010 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $16.7237, valued at
$133.8k
Sold 8,000 shares
@ $16.4682, valued at
$131.7k
Exercised 8,000 options to buy
@ $0.7434, valued at
$5.9k
Exercised 8,000 options to buy
@ $0.7434, valued at
$5.9k
|
|
| 02/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2010 |
5
| CHAI CHRISTOPHER Y (CFO) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 11/04/2009 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 10/05/2009 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 02/11/2009 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/20/2009 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |